Latest Artia Global Partners LP Stock Portfolio
$497Million– No. of Holdings #47
Artia Global Partners LP Performance:
2024 Q1: 18.16%YTD: 18.16%2023: 5%
Performance for 2024 Q1 is 18.16%, and YTD is 18.16%, and 2023 is 5%.
About Artia Global Partners LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Artia Global Partners LP reported an equity portfolio of $497.5 Millions as of 31 Mar, 2024.
The top stock holdings of Artia Global Partners LP are NVO, LLY, MRK. The fund has invested 17.9% of it's portfolio in NOVO-NORDISK A S and 14.5% of portfolio in ELI LILLY & CO.
The fund managers got completely rid off BIOMARIN PHARMACEUTICAL INC (BMRN), WATERS CORP (WAT) and TYRA BIOSCIENCES INC (TYRA) stocks. They significantly reduced their stock positions in NOVO-NORDISK A S (NVO). Artia Global Partners LP opened new stock positions in VERTEX PHARMACEUTICALS INC (VRTX), DISC MEDICINE INC and CRINETICS PHARMACEUTICALS IN (CRNX). The fund showed a lot of confidence in some stocks as they added substantially to RAPT THERAPEUTICS INC (RAPT), APOGEE THERAPEUTICS INC and INTRA-CELLULAR THERAPIES INC (ITCI).
The top stock holdings of Artia Global Partners LP are NVO, LLY, MRK. The fund has invested 17.9% of it's portfolio in NOVO-NORDISK A S and 14.5% of portfolio in ELI LILLY & CO.
The fund managers got completely rid off BIOMARIN PHARMACEUTICAL INC (BMRN), WATERS CORP (WAT) and TYRA BIOSCIENCES INC (TYRA) stocks. They significantly reduced their stock positions in NOVO-NORDISK A S (NVO). Artia Global Partners LP opened new stock positions in VERTEX PHARMACEUTICALS INC (VRTX), DISC MEDICINE INC and CRINETICS PHARMACEUTICALS IN (CRNX). The fund showed a lot of confidence in some stocks as they added substantially to RAPT THERAPEUTICS INC (RAPT), APOGEE THERAPEUTICS INC and INTRA-CELLULAR THERAPIES INC (ITCI).
Artia Global Partners LP Equity Portfolio Value
Last Reported on: 15 May, 2024
Artia Global Partners LP Annual Return Estimates Vs S&P 500
Our best estimate is that Artia Global Partners LP made a return of 18.16% in the last quarter. In trailing 12 months, it's portfolio return was 25.89%.
New Buys
| Ticker | $ Bought |
|---|---|
| vertex pharmaceuticals inc | 12,080,500 |
| disc medicine inc | 5,419,110 |
| crinetics pharmaceuticals in | 4,014,660 |
| dyne therapeutics inc | 3,392,260 |
| springworks therapeutics inc | 2,654,440 |
| ascendis pharma a/s | 2,402,700 |
| ideaya biosciences inc | 2,303,350 |
| merus n v | 2,259,200 |
New stocks bought by Artia Global Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| rapt therapeutics inc | 599 |
| apogee therapeutics inc | 493 |
| intra-cellular therapies inc | 405 |
| cytokinetics inc | 178 |
| vaxcyte inc | 97.78 |
| ocular therapeutix inc | 64.7 |
| insmed inc | 57.78 |
| biomea fusion inc | 39.29 |
Additions to existing portfolio by Artia Global Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| novo-nordisk a s | -4.13 |
Artia Global Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| biomarin pharmaceutical inc | -2,785,090 |
| tyra biosciences inc | -142,004 |
| waters corp | -936,659 |
Artia Global Partners LP got rid off the above stocks
Sector Distribution
Artia Global Partners LP has about 67.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 67.4 |
| Others | 32.6 |
Market Cap. Distribution
Artia Global Partners LP has about 38.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MEGA-CAP | 34 |
| UNALLOCATED | 32.6 |
| MID-CAP | 23.5 |
| LARGE-CAP | 4.9 |
| SMALL-CAP | 4.3 |
Stocks belong to which Index?
About 64.4% of the stocks held by Artia Global Partners LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 37.4 |
| Others | 35.6 |
| RUSSELL 2000 | 27 |
Artia Global Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Artia Global Partners LP
Artia Global Partners LP has 47 stocks in it's portfolio. About 64.9% of the portfolio is in top 10 stocks. RAPT proved to be the most loss making stock for the portfolio. VKTX was the most profitable stock for Artia Global Partners LP last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 3.32 | 90,821 | 16,538,500 | unchanged | 0.00 | ||
| ALPN | alpine immune sciences inc | 0.41 | 51,714 | 2,049,940 | new | |||
| ANNX | annexon inc | 0.21 | 147,485 | 1,057,470 | new | |||
| ARGX | argenx se | 2.71 | 34,238 | 13,480,200 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 0.33 | 40,000 | 1,651,200 | new | |||
| ASND | ascendis pharma a/s | 0.48 | 15,894 | 2,402,700 | new | |||
| AXSM | axsome therapeutics inc | 1.41 | 87,848 | 7,010,270 | unchanged | 0.00 | ||
| AZN | astrazeneca plc | 2.60 | 190,752 | 12,923,400 | unchanged | 0.00 | ||
| BMEA | biomea fusion inc | 0.11 | 35,452 | 530,007 | added | 39.29 | ||
| BMRN | biomarin pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRL | charles riv labs intl inc | 0.38 | 6,905 | 1,870,910 | unchanged | 0.00 | ||
| CRNX | crinetics pharmaceuticals in | 0.81 | 85,765 | 4,014,660 | new | |||
| CYTK | cytokinetics inc | 1.26 | 89,525 | 6,276,600 | added | 178 | ||
| DYN | dyne therapeutics inc | 0.68 | 119,488 | 3,392,260 | new | |||
| EYPT | eyepoint pharmaceuticals inc | 0.21 | 51,500 | 1,064,500 | added | 3.00 | ||
| GRTS | gritstone bio inc | 0.05 | 95,170 | 244,587 | unchanged | 0.00 | ||
| IDYA | ideaya biosciences inc | 0.46 | 52,492 | 2,303,350 | new | |||
| IMVT | immunovant inc | 0.14 | 21,397 | 691,337 | unchanged | 0.00 | ||
| INSM | insmed inc | 0.64 | 118,236 | 3,207,740 | added | 57.78 | ||
| ITCI | intra-cellular therapies inc | 2.92 | 210,096 | 14,538,600 | added | 405 | ||